Article
Head and Neck Cancer Stem Cell-Enriched Spheroid Model for Anticancer Compound Screening
16 Jul 2020
Abstract excerpt
Cancer stem cells (CSCs), a rare cell population in tumors, are resistant to conventional chemotherapy and thus responsible for tumor recurrence. To screen for active compounds targeting CSCs, a good CSC-enriched model compatible with high-throughput screening (HTS) is needed. Here, we describe a new head and neck cancer stem cell-enriched spheroid model (SCESM) suitable for HTS analyses of anti-CSC compounds. We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
